Establishment of new amniotic fluid biomarkers that reflect the short- and long-term prognosis of fetal growth restriction children

Establishment of new amniotic fluid biomarkers that reflect the short- and long-term prognosis of fetal growth restriction children - Establishment of new amniotic fluid biomarkers that reflect the short- and long-term prognosis of fetal growth restriction children

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000052569

Enrollment

Registered

2023-11-01

Start date

2023-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

fetal growth restriction

Interventions

None listed

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: singleton pregnancies with fetal growth restriction more than 22 weeks of gestation

Exclusion criteria

Exclusion criteria: severe fetal malformations, lethal fetal chromosomal abnormalities, and multiple pregnancies abruption of placenta, prolapse of umbilical cord, non reassuring fetal status, massive genital hemorrhage due to placenta previa, uterine rupture, and other feto-maternal emergent status

Design outcomes

Primary

Measure	Time frame
fetal death, neonatal and infant death, neurological development at 2 years of age (cerebral palsy, severe developmental delay)	—

Secondary

Measure	Time frame
hospitalization in the neonatal intensive care unit, respiratory distress syndrome, artificial respiration, chronic lung disease, retinopathy of prematurity, necrotizing enterocolitis, cerebral hemorrhage, periventricular leukomalacia, visual and hearing impairment at 2 years of age	—

Countries

Japan

Contacts

Public ContactDaisuke Katsura

Shiga University of Medical Science Department of Obstetrics and Gynecology

katsuo14@belle.shiga-med.ac.jp077-548-2267

Outcome results